UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata

Pediatric dermatology, 2022-03, Vol.39 (2), p.268-272

2022

Volltextzugriff (PDF)

Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement

Clinical and experimental allergy, 2022-06, Vol.52 (6), p.806-811

2022

Volltextzugriff (PDF)

Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy

Clinical and experimental allergy, 2022-06, Vol.52 (6), p.735-746

2022

Volltextzugriff (PDF)

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant‐activating mutation

Clinical & translational immunology, 2024, Vol.13 (2), p.e1493-n/a

2024

Volltextzugriff (PDF)

Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-12, Vol.9 (12), p.4493-4495.e1

2021

Volltextzugriff (PDF)

Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation

Pediatric allergy and immunology, 2014-11, Vol.25 (7), p.714-715

2014

Volltextzugriff (PDF)

Comment on 'Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation'

Pediatric allergy and immunology, 2015-02, Vol.26 (1), p.92-92

2015

Volltextzugriff (PDF)

Probiotic and Peanut Oral Immunotherapy Is Associated With Lasting Improvement In Quality of Life At Four Years Post-treatment

Journal of allergy and clinical immunology, 2020-02, Vol.145 (2), p.AB345

2020

Volltextzugriff (PDF)

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

The lancet child & adolescent health, 2022-03, Vol.6 (3), p.171-184

2022

Volltextzugriff (PDF)

Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotyping

Pathology, 2024-02, Vol.56 (1), p.92-97

2024

Volltextzugriff (PDF)

Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial

The lancet child & adolescent health, 2017-10, Vol.1 (2), p.97-105

2017

Volltextzugriff (PDF)

Umbilical Cord Blood Cell Clearance Post-Infusion in Immune-Competent Children with Cerebral Palsy

Cells, tissues, organs, 2023-12, Vol.212 (6), p.546-553

2023

Volltextzugriff (PDF)

Safety of sibling cord blood cell infusion for children with cerebral palsy

Cytotherapy (Oxford, England), 2022-09, Vol.24 (9), p.931-939

2022

Volltextzugriff (PDF)

The Efficacy and Safety of Probiotic and Peanut Oral Immunotherapy for inducing Desensitization and Sustained Unresponsiveness: Results from a Phase 2b Multi-center Randomized Trial (PPOIT-003)

Journal of allergy and clinical immunology, 2020-02, Vol.145 (2), p.AB335

2020

Volltextzugriff (PDF)

Reactions to Peanut during a Double-Blind Placebo Controlled Food Challenge (DBPCFC) for Enrolment in a Randomized Trial

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB405-AB405

2018

Volltextzugriff (PDF)

Novel Treatments for Established Food Allergies

Current pediatrics reports (Philadelphia, PA), 2016-12, Vol.4 (4), p.178-185

2016

Volltextzugriff (PDF)

Long Term Effects of a Probiotic and Peanut Oral Immunotherapy (PPOIT) Treatment on Peanut Allergic Children

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB136-AB136

2017

Volltextzugriff (PDF)

An update on oral immunotherapy for the treatment of food allergy

Paediatrics and child health, 2016-07, Vol.26 (7), p.304-309

2016

Volltextzugriff (PDF)

MMP-2 serum concentrations predict mortality in hemodialysis patients: a 5-year cohort study

Clinica chimica acta, 2016-01, Vol.452, p.161-166

2016

Volltextzugriff (PDF)

Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke

European journal of internal medicine, 2017-04, Vol.39, p.63-68

2017

Volltextzugriff (PDF)

Evaluation of Severe Combined Immunodeficiency and Combined Immunodeficiency Pediatric Patients on the Basis of Cellular Radiosensitivity

The Journal of molecular diagnostics : JMD, 2015-09, Vol.17 (5), p.560-575

2015

Volltextzugriff (PDF)

Percentages of Activated and Proliferating T-Regulatory Cells Correlate with Peanut-Specific Immunoglobulin-E Level in Peanut Allergic Children

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB226-AB226

2015

Volltextzugriff (PDF)

Corrigendum to “MMP-2 serum concentrations predict mortality in hemodialysis patients: A 5-year cohort study” [Clin. Chim. Acta 452 (January 15, 2016) 161–166]

Clinica chimica acta, 2016-04, Vol.455, p.209-209

2016

Volltextzugriff (PDF)

Probiotics and oral immunotherapy for peanut allergy – Authors' reply

The lancet child & adolescent health, 2017-11, Vol.1 (3), p.e1-e2

2017

Volltextzugriff (PDF)

Dietary Normalization Following A Successful Oral Food Challenge In Children With Food Allergies

Journal of allergy and clinical immunology, 2021-02, Vol.147 (2), p.AB100-AB100

2021

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(93)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata

Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement

Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant‐activating mutation

Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial

Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation

Comment on 'Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation'

Probiotic and Peanut Oral Immunotherapy Is Associated With Lasting Improvement In Quality of Life At Four Years Post-treatment

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotyping

Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial

Umbilical Cord Blood Cell Clearance Post-Infusion in Immune-Competent Children with Cerebral Palsy

Safety of sibling cord blood cell infusion for children with cerebral palsy

The Efficacy and Safety of Probiotic and Peanut Oral Immunotherapy for inducing Desensitization and Sustained Unresponsiveness: Results from a Phase 2b Multi-center Randomized Trial (PPOIT-003)

Reactions to Peanut during a Double-Blind Placebo Controlled Food Challenge (DBPCFC) for Enrolment in a Randomized Trial

Novel Treatments for Established Food Allergies

Long Term Effects of a Probiotic and Peanut Oral Immunotherapy (PPOIT) Treatment on Peanut Allergic Children

An update on oral immunotherapy for the treatment of food allergy

MMP-2 serum concentrations predict mortality in hemodialysis patients: a 5-year cohort study

Different impact of aspirin on renal progression in patients with predialysis advanced chronic kidney disease with or without previous stroke

Evaluation of Severe Combined Immunodeficiency and Combined Immunodeficiency Pediatric Patients on the Basis of Cellular Radiosensitivity

Percentages of Activated and Proliferating T-Regulatory Cells Correlate with Peanut-Specific Immunoglobulin-E Level in Peanut Allergic Children

Corrigendum to “MMP-2 serum concentrations predict mortality in hemodialysis patients: A 5-year cohort study” [Clin. Chim. Acta 452 (January 15, 2016) 161–166]

Probiotics and oral immunotherapy for peanut allergy – Authors' reply

Dietary Normalization Following A Successful Oral Food Challenge In Children With Food Allergies

Suchergebnisse filtern